Clinical Inquiries & Literature FAQ
Evidence-referenced responses to 8 frequent clinical inquiries regarding CPPS pathophysiology, saw palmetto trials, bicycle saddle pressures, and screening.

1. What explains the failure of repeated antibiotic regimens in CPPS?
Category III CPPS is non-infectious in over 90% of cases. The clinical manifestations reflect pelvic floor hypertonicity, neural sensitization, and microvascular ischemia rather than active bacterial colonization [1].
2. What is the consensus on saw palmetto herbal extracts?
High-quality double-blind placebo-controlled trials (such as the CAMUS trial) have shown no statistically significant superiority of saw palmetto extract over placebo for lower urinary tract symptom management [2].
3. How does bicycle riding impact pelvic hemodynamics?
Narrow, rigid saddles compress the pudendal neurovascular bundle against the pubic bone, reducing penile oxygen tension and triggering pelvic spasms. Utilizing wider ergonomic split-nose saddles mitigates this compression.
4. How is PSA testing accessed through Indonesian BPJS?
Consult the primary care physician at your registered Faskes 1 facility. Upon clinical indication, a formal Surat Rujukan will be provided for hospital-based urological diagnostic workups.
5. What clinical presentations warrant emergency room evaluation?
Acute urinary retention (inability to void), visible hematuria, or high fever accompanied by severe pelvic pain require immediate emergency clinical intervention.
FAQ entries are for academic educational reference only and do not replace personalized clinical consultations.
- [1]Nickel JC, et al. Research guidelines for chronic prostatitis. Urology. 2005;65(5):845-850.
- [2]Barry MJ, et al. Effect of increasing doses of saw palmetto on lower urinary tract symptoms. JAMA. 2011;306(12):1344-1351.